Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis

Conclusions Baseline bone markers can be useful as predictors for disease progression and survival time in patients with bone metastasis from treatment-naïve prostate cancer treated with upfront zoledronic acid concomitantly started with androgen-deprivation therapy.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research